Nanomaterial safety and nanomedicine

Acronym: NANOSafety


The different datasets are contributing to the support for EU regulation on nanomaterials , anticipation of regulatory needs for nanomedicines. The data derive from vairous sources: 3 surveys, proteomics data, transcriptomics data, literature review data, terminology data (processed) and experiment data produced in the frame of institutional and exploratory projects.


Pascal.COLPO (at)

Science Areas

Health and consumer protection

Datasets (7)

DATASET | Last updated:
Characterization of Liposome-based Nanomaterials

In order to provide guidelines to design and perform a robust and reliable physical-chemical characterization of liposome-based nanomaterials, and to support method development wit...

DATASET | Last updated:
Blood compatibility of nanomedicines

Collection of the current knowledge (in vitro and in vivo studies) related to the blood compatibility of nanomedicines and nanomaterials with a potential use in biomedical applicat...

Additional information

Published by
European Commission, Joint Research Centre
Created date
Modified date